BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30273764)

  • 1. Radiation safety analysis for the A-BNCT facility in Korea.
    Lee E; Lee CW; Cho G
    Appl Radiat Isot; 2018 Dec; 142():92-103. PubMed ID: 30273764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shielding design of a treatment room for an accelerator-based epithermal neutron irradiation facility for BNCT.
    Evans JF; Blue TE
    Health Phys; 1996 Nov; 71(5):692-9. PubMed ID: 8887513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A shielding design for an accelerator-based neutron source for boron neutron capture therapy.
    Hawk AE; Blue TE; Woollard JE
    Appl Radiat Isot; 2004 Nov; 61(5):1027-31. PubMed ID: 15308187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Project for the development of the linac based NCT facility in University of Tsukuba.
    Kumada H; Matsumura A; Sakurai H; Sakae T; Yoshioka M; Kobayashi H; Matsumoto H; Kiyanagi Y; Shibata T; Nakashima H
    Appl Radiat Isot; 2014 Jun; 88():211-5. PubMed ID: 24637084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a BNCT irradiation room based on proton accelerator and beryllium target.
    Magni C; Postuma I; Ferrarini M; Protti N; Fatemi S; Gong C; Anselmi-Tamburini U; Vercesi V; Battistoni G; Altieri S; Bortolussi S
    Appl Radiat Isot; 2020 Nov; 165():109314. PubMed ID: 32768928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary shielding assessment for the 100 MeV proton linac (KOMAC).
    Lee YO; Cho YS; Chang J
    Radiat Prot Dosimetry; 2005; 115(1-4):569-72. PubMed ID: 16381787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shielding design calculations for beam dump facility of KOMAC.
    Cho YS; Lee YO; Chang J
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):259-63. PubMed ID: 16604640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shielding design and dose assessment for accelerator based neutron capture therapy.
    Howard WB; Yanch JC
    Health Phys; 1995 May; 68(5):723-30. PubMed ID: 7730072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCNPX vs. DORT for SNS shielding design studies.
    Popova II
    Radiat Prot Dosimetry; 2005; 115(1-4):559-63. PubMed ID: 16381785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the radiation field and shielding assessment of the experimental area of HIE-ISOLDE.
    Romanets Y; Bernardes AP; Dorsival A; Gonçalves IF; Kadi Y; di Maria S; Vaz P; Vlachoudis V; Vollaire J
    Radiat Prot Dosimetry; 2014 Oct; 161(1-4):347-51. PubMed ID: 24591727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of radiation shielding for the proton therapy facility at the National Cancer Center in Korea.
    Kim JW; Kwon JW; Lee J
    Radiat Prot Dosimetry; 2005; 115(1-4):271-5. PubMed ID: 16381727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-power electron beam tests of a liquid-lithium target and characterization study of (7)Li(p,n) near-threshold neutrons for accelerator-based boron neutron capture therapy.
    Halfon S; Paul M; Arenshtam A; Berkovits D; Cohen D; Eliyahu I; Kijel D; Mardor I; Silverman I
    Appl Radiat Isot; 2014 Jun; 88():238-42. PubMed ID: 24387907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BSA modeling for the accelerator-based BNCT facility at INFN LNL for treating shallow skin melanoma.
    Ceballos C; Esposito J
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S274-7. PubMed ID: 19376724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ISABELLE shielding criteria and design.
    Gollon PJ; Casey WR
    Health Phys; 1984 Jan; 46(1):123-32. PubMed ID: 6319330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical shielding calculations for a proton therapy facility.
    Avery S; Ainsley C; Maughan R; McDonough J
    Radiat Prot Dosimetry; 2008; 131(2):167-79. PubMed ID: 18487617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Spallation Neutron Source (SNS) project: a fertile ground for radiation protection and shielding challenges.
    Gallmeier FX; Ferguson PD; Popova II; Iverson EB
    Radiat Prot Dosimetry; 2005; 115(1-4):23-32. PubMed ID: 16381678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of an accelerator-based epithermal neutron source for neutron capture therapy.
    Kononov OE; Kononov VN; Bokhovko MV; Korobeynikov VV; Soloviev AN; Sysoev AS; Gulidov IA; Chu WT; Nigg DW
    Appl Radiat Isot; 2004 Nov; 61(5):1009-13. PubMed ID: 15308184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and construction of an accelerator-based boron neutron capture therapy (AB-BNCT) facility with multiple treatment rooms at the Southern Tohoku BNCT Research Center.
    Kato T; Hirose K; Tanaka H; Mitsumoto T; Motoyanagi T; Arai K; Harada T; Takeuchi A; Kato R; Yajima S; Takai Y
    Appl Radiat Isot; 2020 Feb; 156():108961. PubMed ID: 31683088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and verification of the shielding around the new Neutron Standards Laboratory (LPN) at CIEMAT.
    Méndez-Villafañe R; Guerrero JE; Embid M; Fernández R; Grandio R; Pérez-Cejuela P; Márquez JL; Alvarez F; Ortego P
    Radiat Prot Dosimetry; 2014 Oct; 161(1-4):393-7. PubMed ID: 24478306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation protection modelling for 2.5 Petawatt-laser production of ultrashort x-ray, proton and ion bunches: Monte Carlo model of the Munich CALA facility.
    Englbrecht FS; Döpp A; Hartmann J; Lindner FH; Groß ML; Wirth HF; Thirolf PG; Karsch S; Schreiber J; Parodi K; Dedes G
    J Radiol Prot; 2020 Sep; 40(4):. PubMed ID: 32702682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.